Regentis Biomaterials Ltd (RGNT) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2017 and annually, average high and low, overall ranking from Dec 31 2025 to Sep 30 2017 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Regentis Biomaterials Ltd   (RGNT)

Regentis Biomaterials Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Regentis Biomaterials Ltd in the fourth quarter 2025?
Regentis Biomaterials Ltd recorded a cumulative net loss of $-14 million during 12 months ending in the fourth quarter 2025, resulting in a negative return on equity (ROE) of -287.69%.

Within the Medical Equipment & Supplies industry 174 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from to 4475.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2017)
III. Quarter
Y / Y Equity Change - -1.45 % -8.66 % 706.06 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -14 0 0 0 0
Return On Equity (TTM) -287.69 % - - - -
RGNT's Total Ranking # 4475 # # # #
Equity (TTM) in Millions 5 5 5 5 -41
Seq. Equity Change 0 % 0 % 0 % - -
Seq. Net Income Change - - - - -

Back to RGNT Management Effectiveness >> RGNT's 5 Years Annual ROE >> Compare RGNT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 175
Sector # 782
Overall # 4475

Return On Equity Statistics
High Average Low
19.24 %
-72.48 %
-287.69 %
(Dec 31 2013)   (Dec 31 2025)





RGNT Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2010)
2011
Total Equity in Millions 5 1 1 1 1
Y / Y Equity Change 635.46 % 23.01 % -0.01 % -12.63 % -
Net Income in Millions -14 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -287.69 % -10.14 % 19.24 % -11.31 % 31.39 %

Back to RGNT Management Effectiveness >> RGNT's 5 Years Annual ROE >> Compare RGNT ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RGNT's' Return on Equity at Yahoo Finance
RGNT's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for RGNT's Competitors
Subscribers only: Roe for Regentis Biomaterials Ltd 's Suppliers
Subscribers only: Return On Equity for RGNT's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE

Date modified: 2026-07-07T13:05:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.